RUA Life Sciences plc (AIM: RUA)
London
· Delayed Price · Currency is GBP · Price in GBX 13.48
+0.48 (3.69%)
Jan 22, 2025, 8:14 AM GMT+1
RUA Life Sciences Income Statement
Financials in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 2.92 | 2.19 | 2.18 | 1.63 | 1.53 | 0.49 | Upgrade
|
| Revenue | 2.92 | 2.19 | 2.18 | 1.63 | 1.53 | 0.49 | Upgrade
|
| Revenue Growth (YoY) | 56.29% | 0.55% | 34.09% | 6.35% | 212.47% | 5.62% | Upgrade
|
| Cost of Revenue | 0.55 | 0.48 | 0.45 | 0.35 | 0.28 | - | Upgrade
|
| Gross Profit | 2.37 | 1.72 | 1.73 | 1.27 | 1.25 | 0.49 | Upgrade
|
| Selling, General & Admin | 2.15 | 2.48 | 2.61 | 2.17 | 2.82 | 1.21 | Upgrade
|
| Research & Development | 0.87 | 0.87 | 1.07 | 0.91 | - | - | Upgrade
|
| Other Operating Expenses | -1.11 | -0.06 | -0.01 | 0.22 | -0.28 | -0.01 | Upgrade
|
| Operating Expenses | 2.28 | 3.65 | 4.03 | 3.62 | 2.8 | 1.43 | Upgrade
|
| Operating Income | 0.09 | -1.94 | -2.31 | -2.35 | -1.55 | -0.94 | Upgrade
|
| Interest Expense | -0.08 | -0.08 | -0.02 | -0.01 | -0.04 | - | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0.04 | Upgrade
|
| EBT Excluding Unusual Items | 0.01 | -2.02 | -2.32 | -2.36 | -1.59 | -0.9 | Upgrade
|
| Pretax Income | 0.01 | -2.02 | -2.32 | -2.36 | -1.59 | -0.9 | Upgrade
|
| Income Tax Expense | -0.2 | -0.58 | -0.32 | -0.29 | -0.14 | -0.08 | Upgrade
|
| Earnings From Continuing Operations | 0.21 | -1.44 | -2 | -2.07 | -1.45 | -0.82 | Upgrade
|
| Net Income | 0.21 | -1.44 | -2 | -2.07 | -1.45 | -0.82 | Upgrade
|
| Net Income to Common | 0.21 | -1.44 | -2 | -2.07 | -1.45 | -0.82 | Upgrade
|
| Shares Outstanding (Basic) | 53 | 34 | 22 | 22 | 18 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 53 | 34 | 22 | 22 | 18 | 15 | Upgrade
|
| Shares Change (YoY) | 141.09% | 51.21% | - | 25.36% | 20.50% | 13.75% | Upgrade
|
| EPS (Basic) | 0.00 | -0.04 | -0.09 | -0.09 | -0.08 | -0.06 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.04 | -0.09 | -0.09 | -0.08 | -0.06 | Upgrade
|
| Free Cash Flow | -0.72 | -1.38 | -1.6 | -3.26 | -2.03 | -0.44 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.07 | -0.15 | -0.11 | -0.03 | Upgrade
|
| Gross Margin | 81.10% | 78.32% | 79.30% | 78.22% | 81.94% | 100.00% | Upgrade
|
| Operating Margin | 3.01% | -88.41% | -105.83% | -144.74% | -101.51% | -192.43% | Upgrade
|
| Profit Margin | 7.05% | -65.72% | -91.92% | -127.20% | -94.96% | -166.87% | Upgrade
|
| Free Cash Flow Margin | -24.51% | -63.12% | -73.20% | -200.43% | -133.12% | -90.59% | Upgrade
|
| EBITDA | 0.45 | -1.57 | -1.95 | -2.04 | -1.3 | -0.78 | Upgrade
|
| EBITDA Margin | 15.23% | -71.79% | -89.40% | -125.72% | -84.88% | -159.71% | Upgrade
|
| D&A For EBITDA | 0.36 | 0.36 | 0.36 | 0.31 | 0.25 | 0.16 | Upgrade
|
| EBIT | 0.09 | -1.94 | -2.31 | -2.35 | -1.55 | -0.94 | Upgrade
|
| EBIT Margin | 3.01% | -88.41% | -105.83% | -144.74% | -101.51% | -192.43% | Upgrade
|
| Advertising Expenses | - | 0.01 | 0.02 | 0.01 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.